Your browser doesn't support javascript.
loading
Safer Solvents for Active Pharmaceutical Ingredient Purification Using Column Chromatography.
Ayafor, Christian; Burton, Toren; George, Nathaniel; Morose, Gregory; Wong, Hsi-Wu.
  • Ayafor C; Energy Engineering Program, University of Massachusetts Lowell, Lowell, Massachusetts 01854, United States.
  • Burton T; Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, Massachusetts 01854, United States.
  • George N; Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, Massachusetts 01854, United States.
  • Morose G; Massachusetts Toxics Use Reduction Institute, Lowell, Massachusetts 01854, United States.
  • Wong HW; Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, Massachusetts 01854, United States.
ACS Environ Au ; 4(5): 236-247, 2024 Sep 18.
Article en En | MEDLINE | ID: mdl-39309977
ABSTRACT
Column chromatography is a technique widely used for the purification of active pharmaceutical ingredients (APIs). One of the common solvent systems used by this technique is blends of dichloromethane (DCM) and methanol (MeOH), thereby exposing workers to health and safety risks and making the pharmaceutical sector one of the major contributors to chlorinated solvent waste. In this work, API separation and purification using several alternative safer solvent blends in column chromatography were evaluated and compared to DCM/MeOH. Ibuprofen and acetaminophen were used as model APIs, and caffeine was used as a model additive. Overall, some of the safer solvent blends tested provided better performance, with higher API recovery and purity compared to DCM/MeOH, in addition to potential health, safety, and environmental benefits. Specifically, blends of heptane/ethyl acetate and heptane/methyl acetate showed the most promise. Our work demonstrates the potential of these safer solvent blends as possible replacements for DCM/MeOH in API purification, thereby addressing a critical safety concern in the pharmaceutical industry.